BHCM
ELVN icon

Brevan Howard Capital Management’s Enliven Therapeutics ELVN Stock Holding History

Brevan Howard Capital Management’s Portfolio ELVN Stock Details ELVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10,144
Closed -$228K – 1201
2024
Q4 		$228K Buy
+10,144
New +$228K ﹤0.01% 840